Prevention of Adjuvant Treatment Induced Cardiotoxicity in Egyptian Breast Cancer (BC) Patients: A Randomized Prospective Study
Azza M. Adel, Niven M. Gado, Dina Ragab, Yasmin Abdelrazek Ali, Ahmed Samir & Hagar Ibrahim · Journal of Cancer and Tumor International · 2022
Background: Adjuvant Anthracyclines Chemotherapy (ANTC) and trastuzumab have been documented to prolong survival in patients with breast cancer (BC). However, these drugs are also well known to induce left ventricular systolic dysfunction (LVSD). Multiple studies have shown that...
Open access
Research Article
10.9734/jcti/2022/v12i330177